Summary of Frontier Group Holdings Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Frontier Group Holdings due to lower revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. Financial Expectations - The upcoming earnings report is expected to show a quarterly loss of $0.28 per share, reflecting a year-over-year change of -300% [3]. - Revenues are projected to be $933.63 million, down 4.1% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 229.07% over the last 30 days, indicating a significant reassessment by analysts [4]. - The Most Accurate Estimate for Frontier Group is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -3.52% [12]. Earnings Surprise History - In the last reported quarter, Frontier Group was expected to post a loss of $0.22 per share but actually reported a loss of -$0.19, resulting in a surprise of +13.64% [13]. - Over the last four quarters, the company has beaten consensus EPS estimates three times [14]. Industry Comparison - In the Zacks Transportation - Airline industry, Sun Country Airlines is expected to post earnings of $0.12 per share, indicating a year-over-year change of +100% [18]. - Sun Country Airlines' revenue is expected to be $254.49 million, with a consensus EPS estimate revised 13.2% higher, resulting in an Earnings ESP of +8.7% [19][20].

Core Viewpoint - The market anticipates Toast (TOST) to report a significant year-over-year increase in earnings driven by higher revenues, with actual results being crucial for near-term stock price movements [1][2]. Earnings Expectations - Toast is expected to report quarterly earnings of $0.24 per share, reflecting a year-over-year increase of +1100% [3]. - Revenue projections stand at $1.53 billion, which is a 23.4% increase compared to the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analysts' assessments [4]. - A positive Earnings ESP of +1.70% suggests that analysts have recently become more optimistic about Toast's earnings prospects [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive reading is a strong predictor of an earnings beat, especially when combined with a favorable Zacks Rank [10]. - Toast currently holds a Zacks Rank of 4, which complicates the prediction of an earnings beat despite the positive Earnings ESP [12]. Historical Performance - In the last reported quarter, Toast was expected to post earnings of $0.19 per share but exceeded expectations with earnings of $0.20, resulting in a surprise of +5.26% [13]. - Over the past four quarters, Toast has beaten consensus EPS estimates three times [14]. Conclusion - While Toast does not appear to be a compelling candidate for an earnings beat, investors should consider other factors influencing stock performance ahead of the earnings release [17].

Core Viewpoint - Voya Financial (VOYA) is anticipated to report a year-over-year decline in earnings due to lower revenues, with the upcoming earnings report expected to significantly influence its stock price [1][2]. Earnings Expectations - The consensus estimate for Voya's quarterly earnings is $2.09 per share, reflecting a year-over-year decrease of 7.9% [3]. - Expected revenues for the quarter are $298.2 million, down 8% from the same quarter last year [3]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised down by 1.9%, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for Voya is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -0.08% [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the likely deviation of actual earnings from the consensus estimate, with a strong predictive power for positive readings [9][10]. - Voya's current Zacks Rank is 3 (Hold), complicating predictions of an earnings beat [12]. Historical Performance - In the last reported quarter, Voya exceeded the expected earnings of $1.59 per share, achieving actual earnings of $2.15, resulting in a surprise of +35.22% [13]. - Voya has beaten consensus EPS estimates in each of the last four quarters [14]. Conclusion - Voya does not appear to be a compelling candidate for an earnings beat based on current estimates and revisions, but other factors should also be considered by investors [17].

Select Water Solutions, Inc. (WTTR) is expected to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The earnings report, which is expected to be released on August 5, might help the stock move higher if these key numbers ...

Upstart Holdings, Inc. (UPST) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on ...

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Evolus, Inc. despite higher revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. Earnings Expectations - Evolus is expected to report a quarterly loss of $0.09 per share, reflecting a year-over-year change of -28.6%, while revenues are projected to be $82.93 million, an increase of 23.9% from the previous year [3]. - The earnings report is scheduled for August 5, and better-than-expected results could lead to a stock price increase, whereas missing estimates may result in a decline [2]. Estimate Revisions - The consensus EPS estimate for Evolus has remained unchanged over the last 30 days, indicating a stable outlook from covering analysts [4]. - The Most Accurate Estimate for Evolus is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -28.57%, suggesting a bearish sentiment among analysts [11]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict deviations from consensus estimates, but its predictive power is stronger for positive readings [8][9]. - Evolus currently holds a Zacks Rank of 3, making it challenging to predict an earnings beat based on the combination of a negative Earnings ESP and the rank [11]. Historical Performance - In the last reported quarter, Evolus was expected to post a loss of $0.10 per share but actually reported a loss of -$0.18, resulting in a surprise of -80.00% [12]. - The company has not beaten consensus EPS estimates in any of the last four quarters, indicating a trend of underperformance [13]. Industry Comparison - ResMed, a peer in the Zacks Medical - Products industry, is expected to report earnings per share of $2.46 for the same quarter, reflecting a year-over-year change of +18.3%, with revenues projected at $1.32 billion, up 8.2% from the previous year [17]. - ResMed's consensus EPS estimate has been revised up by 0.5% over the last 30 days, and it has a positive Earnings ESP of +5.16%, suggesting a likelihood of beating consensus estimates [18].

Core Viewpoint - CryoPort, Inc. (CYRX) is anticipated to report a year-over-year increase in earnings despite lower revenues, with the upcoming earnings report expected to significantly influence its stock price [1][2]. Earnings Expectations - The consensus estimate indicates a quarterly loss of $0.20 per share, reflecting a year-over-year change of +39.4% [3]. - Revenues are projected to be $41.63 million, which is a decrease of 27.7% compared to the same quarter last year [3]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised 1.72% higher, indicating a positive reassessment by analysts [4]. - The Most Accurate Estimate for CryoPort is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +3.39% [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive Earnings ESP reading is a strong predictor of an earnings beat, especially when combined with a favorable Zacks Rank [10]. - CryoPort currently holds a Zacks Rank of 3, indicating a likelihood of beating the consensus EPS estimate [12]. Historical Performance - In the last reported quarter, CryoPort was expected to post a loss of $0.23 per share but actually reported a loss of -$0.22, resulting in a surprise of +4.35% [13]. - Over the past four quarters, CryoPort has exceeded consensus EPS estimates three times [14]. Industry Context - Schneider National (SNDR), a peer in the Zacks Transportation - Services industry, is expected to report earnings per share of $0.21, unchanged from the previous year, with revenues projected at $1.42 billion, up 8.1% [18]. - Schneider National has an Earnings ESP of +3.08% but holds a Zacks Rank of 4 (Sell), complicating predictions for an earnings beat [19].

The earnings report, which is expected to be released on August 5, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower. Wall Street expects flat earnings compared to the year-ago quarter on higher revenues when EVgo Inc. (EVGO) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-te ...

Core Viewpoint - Esperion Therapeutics (ESPR) is anticipated to report a year-over-year decline in earnings due to lower revenues, which could significantly affect its stock price depending on the actual results compared to estimates [1][3]. Earnings Expectations - The upcoming earnings report is expected to be released on August 5, with a consensus estimate of a quarterly loss of $0.17 per share, reflecting a year-over-year change of -240% [2][3]. - Revenues are projected to be $66.29 million, down 10.2% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 3.13% lower in the last 30 days, indicating a reassessment by analysts regarding the company's earnings prospects [4]. - The Most Accurate Estimate for Esperion is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -5.88%, suggesting a bearish outlook from analysts [11]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict the deviation of actual earnings from consensus estimates, but its predictive power is significant mainly for positive readings [8][9]. - Esperion's current Zacks Rank is 3 (Hold), which complicates the prediction of an earnings beat [11]. Historical Performance - In the last reported quarter, Esperion was expected to post a loss of $0.18 per share but actually reported a loss of $0.21, resulting in a surprise of -16.67% [12]. - Over the past four quarters, the company has beaten consensus EPS estimates two times [13]. Industry Comparison - In contrast, BioCryst Pharmaceuticals (BCRX) is expected to post earnings of $0.03 per share for the same quarter, indicating a year-over-year change of +150%, with revenues expected to be $148.85 million, up 36.2% from the previous year [17][18].

Revenues are expected to be $354.45 million, down 8.9% from the year-ago quarter. Estimate Revisions Trend The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period. Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change. Price, Consensus and EPS ...